Professional Documents
Culture Documents
AZN
ASTRAZENECA PLC
9,924.00
GBp
+164.00+1.68%
1849432D
CURRENT
Private Company
Tracking Covid-19
224,454
New cases reported worldwide, June 18
6,318,139
Total deaths reported worldwide
12,022,021,894
Vaccine doses administered in 184 countries
+3%
Change in MSCI World Index of global stocks since Jan. 23, 2020
+1.493
Change in U.S. treasury bond yield since Jan. 23, 2020
Open
In October 2020, a few weeks before the experimental trial results for the
BioNTech-Pfizer, Moderna and Oxford/AstraZeneca Covid-19 vaccines
were released, German virologist Christian Drosten cautioned that the
shots would be of limited effectiveness in preventing the spread of the
disease.
“We are dealing here with an infection of the mucous membrane, i.e., in
the nose and the throat and then later the lungs,” he said on Episode 62 of
Das Coronavirus-Update, the podcast launched by broadcaster NDR in
March 2020 that helped make Drosten a household name in Germany.
“The mucous membranes already have their own special local immune
system. With the current vaccines, which are more likely to be injected
into the muscle, you don’t reach this local immune system so well.” As a
result, the vaccines “probably protect more against the severe course [of
the disease] than against infection.”
More from
BloombergOpinion
Biden Is Delivering on His Bipartisan Promise
Housing’s Slowdown Has Economy on the Edge
A Conservative Plan to Strengthen Families, Post-Roe
Populism Isn’t the Answer to Colombia’s Problems
Which is of course exactly how things played out. The vaccines have
been spectacularly effective at preventing severe disease and death, much
less so at preventing transmission.
Drosten has been described in the U.S. media as “Germany’s Fauci,” but
the moniker seems a little unfair. National Institute of Allergy and
Infectious Diseases Director Anthony Fauci was a top researcher in his
day, but has been running a sizable government agency (fiscal year 2021
budget, $6 billion) for the past 38 years. His appearances in the media
during the pandemic have mostly involved reciting the public-health
consensus of the moment, which was useful when the U.S. president was
a font of Covid-19 misinformation but not always especially
enlightening. Drosten, director of the Institute of Virology at
Berlin’s Charité medical school, is perhaps the world’s leading
coronavirus expert, responsible for identifying the original severe acute
respiratory syndrome virus in 2003 and devising the first diagnostic
test for the Covid-causing SARS-CoV-2 virus in January 2020. His
public commentary, delivered chiefly in podcast form after he grew
frustrated dealing with some in the German media, has tended toward
the cutting-edge and forward-looking — as indicated by what he was
saying about vaccines in October 2020.
I recount all this as context for what Drosten said last month in the 113th
and final (for now) regular Coronavirus-Update episode. He was talking
again about the mucous membrane — which in German is conveyed as
the more graphic “Schleimhaut,” literally “slime skin” — and its role in
keeping infectious diseases in check (translation and editing-for-brevity
by me):
With influenza it is simply the case that everyone gets infected x times
over the course of their lives. These infections occur in the mucous
membrane, in the throat. Our mucous membranes have a local immune
system of their own, if you want to call it that. And everyone in the
population, except for the children, of course, has so many infections
behind them that there in the mucous membrane, immunity exists. That
is why the adults in the population, and that is the vast majority of the
population, are not so infectious.
One thing that could preclude this, Drosten speculated, might be a lot of
young people (the “Party Generation,” he called it, in English) getting
infected a second or third time over the summer, but he expressed doubt
that this would be enough to make a difference in 2022. How many times
are people going to need to be infected to confer effective immunity
against transmission, asked NDR science reporter and podcast moderator
Korinna Hennig. Drosten’s reply:
My idea is that this is in the range of a number that you can count on one
hand. But no one can say for sure at the moment.
Over the long run, we will not be able to vaccinate the population every
few months. That won’t do. At some point, the virus itself will have to
keep updating people’s immunity.
Given the source, it’s hard to argue with this. As a guide to policy and
behavior, though, it’s not so clear. Going to great lengths to avoid
infection makes less sense for most of us than it used to, and trying to
maintain a zero-Covid policy as a nation, as China is doing, seems to
make no sense at all. But should we be going out and trying to get
infected?
A few weeks ago, after writing about my belief that wearing masks on
buses and subways ought be encouraged even after the mandates go
away, I heard from readers who argued that this was unwise because
getting exposed to germs on the bus or subway builds immunity. But if
that’s the case, the great majority of Americans who aren’t fortunate
enough to commute by public transportation must be putting themselves
in grave danger. By that logic, don’t they need to hang out unmasked in
enclosed spaces crowded with strangers for a couple of hours every
week?
Put it that way, and the argument for not ever bothering to
take precautions falls apart. Drosten certainly doesn’t subscribe to it,
instead expressing hope in the final Coronavirus-Update that the “Asian
courtesy” of wearing a mask when ill and in certain other situations
catches on in Germany. Wondering what the right balance might be, I
asked my primary-care physician (and college classmate) Bertie
Bregman, who has been treating Covid patients in New York since the
early days of the pandemic and contracted the disease early on, too. He
had an interesting response: “In a nutshell, what I believe is that we have
to stop being so neurotic about Covid and be more neurotic about
everything else.”